Rod Raynovich
Contributor since: 2010
Company: Raygent Capital
Posts
Large Cap Biopharmaceuticals Are Lagging: 2019 Performance Snapshot-XBI Is Pick For Bulls
J.P.Morgan Healthcare Conference: Picks And Trades Update-AMRN,GNML,TDOC
2018 Biopharmaceutical Performance-Large Caps: Big Winners Were Merck And Vertex
Biotech Momentum Lost Mired In Macro-Economic News Cycle: China, FED,Trade Etc.
Is Bullish Sentiment Too High For Biotech?
ASCO 2018 Biotech Rally: Can We Break-Out Of Triple Top?
Busted Biotech Stocks: Where Do We Go From Here?
Rayno BioBeat 2018 #2: Biotech Deal Sparks Rally
2018 J.P.Morgan Healthcare Conference #4 Notes From Panel: Key Trends In Diagnostics And Lifesciences
Biotech ETFs Vs Active Funds: Fidelity Biotech Fund Outperforms The IBB
Rayno Biopharma Portfolio 2017 Summary Performance
Market Rockets To Record But Biotechs Are Left Behind
Rayno BioBeat #7: Biotech Green Screen Day Off Recent Bottom.Update-1
Biotech Correction: Just A Market Rotation Or Slower Growth Ahead?
Rayno Biopharmaceutical Portfolio: Celgene Added Today
Biotech Bull Market Update: Five Year Performance For Life Science Funds And ETFs
Biotech Momentum Eases: September Is A Bit Sluggish
Rayno Biopharmaceuticals Portfolio In A Biotech Bull Market
ASCO Abstracts Week: Biotech Trends And Hot Stocks
Biotechs Running Again: Rayno Life Science Stocks-See Picks...Earnings Updates
Which Market Sector Leads Year To Date?
Biotech In A Doldrums: Rallies Interrupted By Geopolitics, Trump Agenda And Flight To Safety
Biotech Stocks Sink With Broad Sell-Off On Political Realities
Biotech Rally Clipped By Trump Tweet; ACA Makeover Creates Uncertainty
More Drug Pricing Headwinds; Upticks On M&A
Large Cap Biopharma: January'17 Update-2
Biotech Blahs Worsened By Political Distractions
2017 J.P.Morgan Healthcare Conference Notes #1: Investors Buy Selective Biotech Stocks-ILMN, INCY, REGN,RDUS
Biotech Blahs: Out Of Favor But Great For Stock Pickers
Biotechs Unhinged By Tough Pricing Talk
Alert: Alzheimer's Drug Fails In Clinical Trial-Stocks Sink: ACIU,BIIB,LLY...Update-1
Sector Shift Underway Leaving Biotech Stocks Behind